Neuron23
South San Francisco, US · 4 known investors
Neuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease. It aims to match patient subsets defined by genetic drivers with targeted therapies for conditions such as Parkinson's and Alzheimer's.
AI & Machine LearningBiotechDeep TechDigital Health
Founders & leadership
NS
Nancy StaglianoinCEO
Investors · 4
In the news
Frequently asked questions
- What does Neuron23 do?
- Neuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease. It aims to match patient subsets defined by genetic drivers with targeted therapies for conditions such as Parkinson's and Alzheimer's.
- Who are Neuron23's investors?
- Neuron23's investors include Kleiner Perkins, SoftBank Group, SoftBank Vision Fund, Westlake Village BioPartners.
- Where is Neuron23 headquartered?
- Neuron23 is headquartered in South San Francisco, US.